Camtek: I Am Using 27x Earnings Instead Of 40x

Wait 5 sec.

IsraelOct 28, 2026, 8:50 AM ETCamtek Ltd. (CAMT) StockFoundry Research93 FollowersCamtek is rated Hold, as the current valuation already reflects its robust growth outlook and order momentum.CAMT targets doubling revenue to $1.2B by 2029, driven by advanced packaging, service, and software expansion.Projected margin improvements—up to 35% operating margin—are offset by cyclical risks, competition, and heavy China exposure.Discounted 2029 earnings at a reasonable 27x multiple yield little upside from today’s price, justifying a neutral stance.franckreporter/iStock via Getty ImagesI take Camtek Ltd.'s (CAMT) 2029 estimated earnings, and I assign a somewhat random 22x multiple to it, and I get a sell rating because there's hardly any upside. But why 22x? IsnThis article was written byFoundry Research93 FollowersFoundry Research is written by a Europe/UK/India-based Electronics and Communication Engineering professional with a B.Tech degree and more than 26 years of industry experience. The author currently works as an onsite expert for a major Indian multinational technology, telecom and software group, with professional exposure across the UK and continental Europe. Foundry Research approaches investing with a technical and engineering-oriented perspective. The focus is on businesses where understanding the underlying technology, engineering economics, competitive position and capital requirements can provide additional insight beyond financial statements alone. Key areas of interest include technology, semiconductors, telecom, software, industrials, engineering, aerospace, automation and other science-driven businesses. The author has been investing in U.S. equities for more than a decade, with particular interest in technology-related companies. The preferred approach is value-oriented, with an emphasis on situations where market expectations appear substantially worse than the underlying business reality, or where a good business has become temporarily mispriced because of a cyclical downturn, execution issues, an unpopular industry, excessive pessimism or misunderstood technology. Foundry Research does not treat statistical cheapness by itself as an investment thesis. Analysis typically considers balance-sheet strength, cash generation, competitive advantages, industry structure, management execution and the realistic path to earnings improvement before arriving at a valuation view. On Seeking Alpha, Foundry Research will primarily cover U.S.-listed technology and industrial companies, while also examining selected European businesses and science-driven opportunities where the author's professional background can provide useful context. The objective is to examine companies from both an investor's and an engineer's perspective, explain what drives the business, and identify situations where market price and long-term value may have diverged.Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.Comments